MMedication Read More FDA accepts BMS protein degrader for review; Disc rare disease drug rejectedFebruary 19, 2026 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
HHealth Read More Scientists say they now know what went wrong with Johnson & Johnson’s Covid vaccineFebruary 14, 2026 The U.S. Food and Drug Administration authorized Johnson & Johnson’s Covid vaccine for emergency use in February 2021,…
HHealth Read More Scientists say they now know what went wrong with Johnson & Johnson’s Covid vaccineFebruary 14, 2026 The U.S. Food and Drug Administration authorized Johnson & Johnson’s Covid vaccine for emergency use in February 2021,…
HHealthcare Read More Johnson & Johnson (JNJ) Q4 earningsJanuary 21, 2026 Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
BBusiness Read More Stock market today: Live updatesJanuary 20, 2026 Trades work at the New York Stock Exchange on Jan. 16, 2026. NYSE Stock futures on Monday night…
HHealthcare Read More I talked to many health CEOs out West and see big things for drug stocksJanuary 18, 2026 We get so caught up in the buzz and the sizzle that we forget about the steak, especially…
HHealthcare Read More The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady GrowthJanuary 10, 2026 jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…
HHealthcare Read More Johnson & Johnson, U.S. agree on drug discounts, new plantsJanuary 9, 2026 Key Terms tariffs regulatory Tariffs are taxes imposed by a government on goods…
HHealthcare Read More J&J strikes deal with U.S. government to cut drug prices, gain tariff exemptionsJanuary 9, 2026 Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
HHealthcare Read More Johnson & Johnson MedTech submits Ottava surgical robot to FDAJanuary 8, 2026 Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
HHealthcare Read More The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & JohnsonJanuary 7, 2026 Chicago, IL – January 6, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…